CAS # 288383-20-0,Cediranib (AZD2171)

Basic Info

Model No.: 288383-20-0

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

We are well known in the market for offering Cediranib CAS 288383-20-0. Excellent quality, high purity, safe and reliable are its features that appreciated by our customers. Cediranib CAS NO 288383-20-0 not only a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases, but also a highly potent inhibitor of recombinant KDR tyrosine kinase activity in vitro (IC50 < 1 nmol/L). We have rich experience and professional express team that can ensure Cediranib 288383-20-0 transported in a safe way.

Thera. Category: A tyrosine kinase inhibitor

Cas No.: 288383-20-0

Synonym: Cediranib;4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline;Cadiranib (AZD2171);Cediranib(AZD2171);AZD2171;Recentin;Cadiranib;Cediranib R

Molecular Formula: C25H27FN4O3

Molecular Weight: 450.51

Assay: ≥98.%

Appearance: Crystalline solid

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Solubility:DMSO (10 mM)

Storage Temp.: -20°C

Shipping Conditions: RT

Handling: Protect from air and moisture

Related Intermediates:

1)CAS # 288383-20-0,Cediranib (AZD2171)

2) CAS #288385-88-6,4-Fluoro-5-hydroxy-2-methylindole

Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.